The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

ProShares Ultra Nasdaq Biotechnology

Nasdaq: BIB
Last

(U.S.) $36.50

Today's change-4.02 -9.92%
Updated June 24 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

ProShares Ultra Nasdaq Biotechnology

Nasdaq: BIB
Last

(U.S.) $36.50

Today's change-4.02 -9.92%
Updated June 24 4:00 PM -4GMT. Delayed by at least 15 minutes.

ProShares Ultra Nasdaq Biotechnology down (U.S.)$4.02

ProShares Ultra Nasdaq Biotechnology closed sharply lower Friday, dropping (U.S.)$4.02 or 9.92% to (U.S.)$36.50. Over the last five days, shares have lost 6.00% and sit 3.61% above their 52-week low. This security has underperformed the S&P 500 by 58.04% during the last year.

Key company metrics

  • Open(U.S.) $37.29
  • Previous close(U.S.) $40.52
  • High(U.S.) $38.75
  • Low(U.S.) $36.50
  • Bid / Ask(U.S.) $36.41 / (U.S.) $36.90
  • YTD % change-48.94%
  • Volume1,403,159
  • Average volume (10-day)606,527
  • Average volume (1-month)575,003
  • Average volume (3-month)775,304
  • 52-week range(U.S.) $35.23 to (U.S.) $106.10
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS--
Updated June 24 4:00 PM -4GMT. Delayed by at least 15 minutes.

Latest Company News

    No News Results.

Latest Press Releases

    No Press Release Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow